Skip to content
The Nexus
DossierENTITY

Phil Rau

Coverage of Phil Rau in the Nexus archive.

Earliest in view: Jul 2 · 22:05 UTCMost recent: Jul 2 · 22:05 UTC
Co-mentioned in this coverage
UVM Healthorganization1Ozempictopic1Zepboundtopic1GLP-1 drugstopic1Kevin Kelleherperson1Steve Lefflerperson1Haley Duquetteperson1
Recent coverage
  • HEALTHJul 2 · 22:05 UTCVTDIGGER
    UVM Health to suspend weight loss drug coverage for its employees

    UVM Health plans to stop covering weight loss medications for employees starting September 2023, aiming to save $19 million annually. The decision affects GLP-1 drugs like Ozempic and Zepbound, which are costly out-of-pocket for employees, while coverage for diabetes treatment remains. Employees express concern over financial burden and health impacts.